Repeated antidepressant treatments induce a long-lasting dopamine autoreceptor subsensitivity: is daily treatment necessary for clinical efficacy?
Antelman, S.M.; Chiodo, L.A.
Psychopharmacology Bulletin 17(1): 92-94
1981
ISSN/ISBN: 0048-5764 PMID: 7232669 Document Number: 168705
Document emailed within 1 workday
Related Documents
Antelman, S.M.; Chiodo, L.A. 1981: Dopamine autoreceptor subsensitivity: a mechanism common to the treatment of depression and the induction of amphetamine psychosis Biological Psychiatry 16(8): 717-727Gangadhar, B.N.; Pradhan, N.; Mayanil, C.S. 1987: Dopamine autoreceptor down-regulation following repeated electroconvulsive shock Indian Journal of Medical Research 86: 787-791
Sluydts, V.; Durnez, L.; Heng, S.; Gryseels, C.; Canier, L.; Kim, S.; Van Roey, K.; Kerkhof, K.; Khim, N.; Mao, S.; Uk, S.; Sovannaroth, S.; Grietens, K.P.; Sochantha, T.; Menard, D.; Coosemans, M. 2016: Efficacy of topical mosquito repellent (picaridin) plus long-lasting insecticidal nets versus long-lasting insecticidal nets alone for control of malaria: a cluster randomised controlled trial LANCET. Infectious Diseases 16(10): 1169-1177
Hjorth, S.; Jackson, D.; Carlsson, A.; Lindberg, P. 1982: A behavioral study of the changes in the CNS of mice after subchronic treatment with the dopamine autoreceptor agonist 3-PPP Psychopharmacology Bulletin 18(4): 149-152
Sorg, B.A.; Davidson, D.L.; Kalivas, P.W.; Prasad, B.M. 1997: Repeated daily cocaine alters subsequent cocaine-induced increase of extracellular dopamine in the medial prefrontal cortex Journal of Pharmacology and Experimental Therapeutics 281(1): 54-61
Okuyama, S.; Shimamura, H.; Hashimoto, S.; Aihara, H. 1986: Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats Archives Internationales de Pharmacodynamie et de Therapie 284(2): 246-254
Nutt, D.J. 2006: The role of dopamine and norepinephrine in depression and antidepressant treatment Journal of Clinical Psychiatry 67(Suppl 6): 3-8
Wolf, J.E.; Kerrouche, N.; Arsonnaud, S. 2006: Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea Cutis 77(4 Suppl): 3-11
Taguchi, K.; Iihara, H.; Ishihara, M.; Komori, Y.; Tanizawa, K.; Matsuura, K.; Itoh, Y. 2009: Comparison of antiemetic efficacy between single and repeated treatments with a 5-HT3 receptor antagonist in breast cancer patients with high-risk emetogenic chemotherapy Anticancer Research 29(5): 1721-1725
Bygbjerg, I.C.; Rønn, A.M. 1999: Long-lasting neuropsychiatric side-effects following mefloquine prophylaxis. a case after six weeks of initiating and lasting six months Ugeskrift for Laeger 161(10): 1422-1423
Moore, A.; Kempers, S.; Murakawa, G.; Weiss, J.; Tauscher, A.; Swinyer, L.; Liu, H.; Leoni, M. 2014: Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study Journal of Drugs in Dermatology: Jdd 13(1): 56-61
Ndiaye, J.Louis.A.; Faye, B.; Diouf, A.M.; Kuété, T.; Cisse, M.; Seck, P.A.; Brasseur, P.; Same-Ekobo, A.; Lameyre, V.; Gaye, O. 2008: Randomized, comparative study of the efficacy and safety of artesunate plus amodiaquine, administered as a single daily intake versus two daily intakes in the treatment of uncomplicated falciparum malaria Malaria Journal 7: 16
Halaris, A.E.; Stern, W.; Harto-Truax, N. 1981: Clinical efficacy of the new antidepressant bupropion (Wellbutrin) Psychopharmacology Bulletin 17(1): 140-142
Hillegaart, V.; Ahlenius, S.; Fowler, C.J.; Magnusson, O. 1988: Increased duration of dopamine receptor antagonist-induced effects on both behaviour and striatal dopamine turnover by repeated testing in rats Pharmacology and Toxicology 63(2): 114-117
Solti, F.; Szatmáry, L.; Rényi-Vámos, F.; Szabó, Z. 1987: Pacemaker therapy for the treatment of the long QT syndrome associated with long-lasting bradycardia and ventricular tachycardia. Electrophysiological characteristic and therapy Cor et Vasa 29(6): 428-435
Burenko, H.V.; Halyha, T.M. 2002: Use of polyurethane "Bioderm" for the treatment of long lasting wounds Klinichna Khirurhiia 2002(11-12): 13-14
Tsymbaliuk, V.I.; Tretiak, I.B.; Tsymbaliuk, I.V. 2013: Surgical treatment of the plexus brachialis injury using long-lasting electrostimulation Klinichna Khirurhiia 6: 59-61
Scatton, B. 1980: Effect of repeated treatment with neuroleptics on dopamine metabolism in cell bodies and terminals of dopaminergic systems in the rat brain Advances in Biochemical Psychopharmacology 24: 31-36
Kikuchi, T.; Tottori, K.; Uwahodo, Y.; Hirose, T.; Miwa, T.; Oshiro, Y.; Morita, S. 1995: 7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity Journal of Pharmacology and Experimental Therapeutics 274(1): 329-336
Rothwell, P.M. 1997: What do the overall results of clinical trials and meta-analyses tell us about the efficacy of treatments? Journal of Nephrology 10(1): 5-6